Emergent BioSolutions is a specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, USA. It develops vaccines and antibody therapeutics for infectious diseases, o—id overdoses, and provides medical devices for biodefense purposes.
Stock price: EBS (NYSE) $44.91 +0.42 (+0.94%)
- Headquarters: Rockville, MD
- Revenue: 782.4 million USD (2018)
- Subsidiaries: PaxVax, Cangene, ADAPT Pharma Inc., CBL/GP Inc, MORE
- Key people: Robert G. Kramer Sr., Fuad El-Hibri